Lampasona V, Mullins R E, Parks R B
Am J Hosp Pharm. 1986 Apr;43(4):921-5.
The stability of ranitidine hydrochloride stored frozen and refrigerated in polyvinyl chloride minibags was studied. Ranitidine hydrochloride was added to either 5% dextrose injection or 0.9% sodium chloride injection to yield concentrations of 0.5, 1.0, and 2.0 mg/mL. In phase 1 of the study, admixtures containing ranitidine hydrochloride 1 mg/mL were stored at 4 degrees C for 10 days. In phase 2, solutions were frozen for 30 days at -30 degrees C and were later refrigerated for 14 days. Ranitidine concentration was tested using a stability-indicating high-performance liquid chromatographic assay at time zero and at intervals during storage. Sterility tests were performed on some samples, and various admixtures were visually inspected and tested for pH. At least 90% of the initial concentration of ranitidine remained in all solutions at all storage conditions. No visual changes or changes in pH or sterility were observed. Ranitidine hydrochloride in concentrations of 0.5, 1.0, and 2.0 mg/mL in 5% dextrose injection or 0.9% sodium chloride injection may be stored in polyvinyl chloride minibags frozen for 30 days followed by refrigeration for an additional 14 days.
研究了盐酸雷尼替丁在聚氯乙烯小袋中冷冻和冷藏时的稳定性。将盐酸雷尼替丁加入5%葡萄糖注射液或0.9%氯化钠注射液中,使其浓度分别为0.5、1.0和2.0mg/mL。在研究的第一阶段,将含有1mg/mL盐酸雷尼替丁的混合液在4℃下储存10天。在第二阶段,溶液在-30℃下冷冻30天,随后在4℃下冷藏14天。在储存开始时及储存期间的各个时间间隔,使用稳定性指示高效液相色谱法检测雷尼替丁浓度。对部分样品进行无菌试验,并对各种混合液进行外观检查和pH值检测。在所有储存条件下,所有溶液中雷尼替丁的初始浓度至少有90%得以保留。未观察到外观变化、pH值变化或无菌状态变化。5%葡萄糖注射液或0.9%氯化钠注射液中浓度为0.5、1.0和2.0mg/mL的盐酸雷尼替丁可在聚氯乙烯小袋中冷冻30天,随后再冷藏14天。